Connect with us
Giftify’s Q2 results mark a decisive turn in the company's history. With debts melting away, cash flow flipped positive, and inventory discipline freeing up capital, the...
Giftify’s targeted campaigns (e.g. discounted Ozempic) have already driven 916% category revenue spikes. Now, they're launching a new travel campaign with up to 16% off major...
After driving a 916% revenue surge with a single campaign, Giftify is scaling the same strategy to accelerate its revenue growth. With ongoing inflation concerns and...
Giftify, Inc. [NASDAQ: GIFT] saw a record 916% increase in category sales revenue following the launch of its GLP-1 savings campaign. Now, the company is building...
Giftify [NASDAQ: GIFT] is disrupting the GLP-1 market with a smart savings model providing consumers with discounted Ozempic and Wegovy. With the FDA closing the loophole...